Back to search
Metastatic Castration Sensitive Prostate Cancer (mCSPC)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Metastatic Castration Sensitive Prostate Cancer (mCSPC) trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Metastatic Castration Sensitive Prostate Cancer (mCSPC) trials you may qualify forThis study will explore whether a combination of the investigational drug mevrometostat (PF-06821497) and enzalutamide will work better than taking enzalutamide…
This study consists of two home-based exercise programs: a stationary exercise bicycle intervention (Arm A), and a walking intervention (Arm B). The study will…
The intention of the study is to demonstrate superiority of Saruparib (AZD5305) + physician's choice NHA relative to placebo + physician's choice NHA by assessm…
Medicines that reduce the amount of testosterone in the body are commonly used to treat prostate cancer. PRL-02 depot is a potential treatment for men with adva…
The purpose of the study is to determine if the combination of niraparib with Abiraterone Acetate (AA) plus prednisone compared with AA plus prednisone in parti…
The purpose of the study is to evaluate the safety and efficacy of talazoparib in combination with enzalutamide compared with placebo in combination with enzalu…